July 12, 2022
by Natalia Honchar
News
Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
May 6, 2022
by Bohdana Sokolova, Andrii Buvailo
Biopharma insight
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
March 22, 2022
by Andrii Buvailo
Interview
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Feb. 4, 2022
by Alan Nafiiev
Biopharma insight
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
Jan. 26, 2022
by Andrii Buvailo
Biopharma insight
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
Jan. 19, 2022
by Alan Nafiiev
Biopharma insight
Over the last five or so years, the drug discovery industry has started adopting artificial intelligence (AI) at unprecedented scale, …
Jan. 3, 2022
by Andrii Buvailo
Biopharma insight
Deep Knowledge Group, a UK-based consortium of commercial and non-for-profit companies in the domain of longevity industry and deep tech …
Oct. 19, 2021
by Andrii Buvailo
Biopharma insight
A Hong Kong-based artificial intelligence (AI)-driven drug discovery company Insilico Medicine has just announced the appointment of Dr. Michelle Chen …
Sept. 24, 2021
by Illia Petrov, Darina Abdulina
Biopharma insight
Over 2020-2021 we have seen a remarkable parade of artificial intelligence (AI), focused on discovering novel therapeutics, going public. This …